← All posts
Press Release 2026-10-14

Molagri raises $5.8M to build precision biopesticides that can keep up with pesticide resistance

The Toronto biotech startup, which went through Y Combinator, is engineering virus-like particles that target specific pest species and leave other insects alone. The round was led by resilience-focused fund Convective Capital.

Molagri raises $5.8M to build precision biopesticides that can keep up with pesticide resistance
Photo by Yasmine Omar (voadan.com)

TORONTO — October 14, 2026 — Molagri is a crop protection startup that engineers biology into precise biopesticides. Today it announced $5.8 million USD ($8.2 million CAD) in total pre-seed and seed funding. Convective Capital led the seed round, with participation from Y Combinator, Superorganism, Robinhood Ventures, Paul Graham and other angels. Julian Capital was the earliest backer, and led the pre-seed.

Insects are becoming resistant to the chemical pesticides farmers rely on, and regulators keep taking existing products off the market. Broad-spectrum insecticides also harm pollinators and other beneficial insects. Growers end up with fewer options that work.

Molagri’s platform is built on non-infectious, engineered virus-like particles (VLPs). Each VLP recognizes receptors found in target pest insects. Once inside the target pest, the VLP delivers genetic instructions that cause the pest’s own cells to produce an insecticidal payload. Beneficial insects lack the receptor, so they aren’t affected. The design is modular, so Molagri can adapt the targeting and payload as pests evolve instead of starting from scratch for each new problem. The company’s first products will target pests in tree nuts and tree fruits, which have an acute need for novel insecticides.

“Farmers shouldn’t have to worry about resistance, the same way you don’t think about which flu strain is going around when you get a flu shot,”

said Zaky Hassan, co-founder and CEO of Molagri.

“We want to be the team that designs the next product before resistance becomes a problem in the field. This funding lets us build out our lab and hire the scientists to get there.” 

Hassan and co-founder and CSO Min Jin are viral structural biologists and protein biochemists from the University of Toronto, where they studied human coronaviruses. Jin holds the world record for the highest-resolution coronavirus spike protein structure in the Protein Data Bank.

“Pesticide resistance is a slow-moving disaster for global food security, and the tools farmers have today weren’t built for a world where pests adapt this quickly,”

said Bill Clerico, Managing Partner at Convective Capital.

“Zaky and Min are bringing the precision of modern protein engineering to agriculture. We think this platform can give growers a durable, targeted alternative to broad-spectrum chemicals.” 

Molagri will use the funding to grow its scientific team and speed up R&D. The company recently expanded into a new Toronto lab with biomanufacturing and tissue culture space and filed a provisional patent on its targeted VLP delivery system. It is currently hiring scientists in insect biology, virology and VLP production.


About Molagri
Molagri engineers biology into precise, biopesticide-based crop protection. Its virus-like particle platform targets specific insect pests and reduces unnecessary environmental impact and cost, and it is designed for scalable fermentation-based manufacturing. Molagri is based in Toronto and went through Y Combinator’s Summer 2026 batch. Learn more at molagri.com.

About Convective Capital
Convective Capital is a venture capital firm investing in technology that helps humanity thrive in an increasingly volatile world. Learn more at convectivecapital.com.

Media contact: Zaky Hassan, inquiries@molagri.com

Talk to us

Be part of the next chapter in crop protection

Book a Call today